St. Joe (JOE) Q2 2025 Earnings Call Transcript

St. Joe reported Q2 revenue up 16% and net income up 20%, with real estate revenue rising 27% and recurring revenue reaching 63% of total revenue in the first half of 2025. Leasing and hospitality revenues both hit quarterly records, while the company returned capital via $10.1 million of buybacks, $8.1 million of dividends, and $7.7 million of project debt reduction. Management also highlighted several long-duration growth catalysts, including approval of the Pigeon Creek DSAP, the $414 million FSU Health hospital bond issuance, a new Delta nonstop route, and continued progress on Margaritaville expansion and marina construction.

Analysis

JOE is transitioning from a land bank monetization story into a cash-yielding operating platform, and that matters because the market typically rewards recurring revenue with a much higher multiple than lumpy entitlement gains. The second-order effect is that every new infrastructure approval, hotel, club, or brokerage launch increases the optionality of adjacent parcels, so the company can compound value without needing to sell core land. In other words, the real asset is no longer just acreage; it is the density of monetization paths around that acreage.

The most interesting catalyst is that several previously binary “future value” items are now moving into execution: a large entitlements package, a hospital development, a new airport route, and an expanded JV footprint. That combination should improve the perceived durability of forward cash flows over the next 12-36 months, but the conversion to earnings is uneven because some assets are still in lease-up or permitting. The near-term risk is that investors overestimate how quickly approvals become cash, especially if mortgage rates stay sticky and lot absorption normalizes after a strong first half.

The capital return signal is more important than it looks. Share count below 58 million suggests management is willing to use the balance sheet to defend per-share value while still funding growth, which can create a rerating if the market starts underwriting JOE as a hybrid of REIT-like cash return plus development upside. The contrarian miss is that the biggest upside may come not from headline EPS growth, but from sustained narrowing of the NAV discount as recurring revenue becomes a bigger share of the mix and the company proves it can return capital without starving the pipeline.

Key Decisions for Investors

• Long JOE vs short a basket of cyclical land/development names for 6-12 months: thesis is multiple expansion from recurring revenue mix shift and visible capital returns; stop if home sales momentum or leasing growth stalls for two quarters.
• Buy JOE on pullbacks with a 3-6 month horizon; target a re-rating as the market digests the share count reduction and recurring revenue mix, with downside cushioned by ongoing buybacks/dividends.
• Sell out-of-the-money JOE calls against a core long position if implied volatility spikes around infrastructure or JV announcements; the stock has catalysts, but execution timing is still slow enough to monetize premium.
• Watch for a long JOE / short regional homebuilder pair if mortgage rates ease: JOE has idiosyncratic infrastructure-driven demand, while pure builders are more rate-sensitive and lack the same land optionality.
• Avoid chasing the headline on the hospital/bond/newsflow trade until permitting and operator agreements are locked; the clean entry is after the market starts seeing actual project spend, not just approvals.